Columbia Laboratories Inc. (CBRX) Stock News, Earnings & History

(NASDAQ:CBRX) Healthcare

Enjoy Interactive Tools and Indicators

52wk high: 1.23
52wk low: 0.55
EPS: 0.05
P/E: 11.70
Div Rate: N/A
Yield: N/A
Market Cap: 54.25M
Avg Vol (3m): 273,575

Latest Headlines

More Articles About CBRX →

Company On Twitter

Company Profile

Columbia Laboratories, Inc. is an international pharmaceutical company that develops and markets women's health care and endocrinology products. The Company develops products intended to treat infertility, dysmenorrhea, endometriosis, and hormonal deficiencies, primarily utilizing its Bioadhesive Delivery System technology. Columbia markets Striant, and Prochieve 8% and 4%.


Investor Relations | Press Releases

Insider Trading Cheat Sheet

No insider trading data available for Columbia Laboratories Inc..

Yahoo, HV, Market Watch, The Wall St. Journal